4.5 Article

The association between XRCC3 rs1799794 polymorphism and cancer risk: a meta-analysis of 34 case-control studies

期刊

BMC MEDICAL GENOMICS
卷 14, 期 1, 页码 -

出版社

BMC
DOI: 10.1186/s12920-021-00965-4

关键词

Rs1799794; Polymorphism; Cancer; Risk; Meta-analysis

资金

  1. Applied Basic Foundation of Yunnan Province [202001AT070009]
  2. Yunnan Health Training Project of High Level Talents [D-2019032]

向作者/读者索取更多资源

Studies on the XRCC3 rs1799794 polymorphism show that it is associated with cancer risk, especially increased risk for breast cancer and thyroid cancer and reduced risk for ovarian cancer. However, further large-scale studies are needed to evaluate the results.
Background Studies on the XRCC3 rs1799794 polymorphism show that this polymorphism is involved in a variety of cancers, but its specific relationships or effects are not consistent. The purpose of this meta-analysis was to investigate the association between rs1799794 polymorphism and susceptibility to cancer. Methods PubMed, Embase, the Cochrane Library, Web of Science, and Scopus were searched for eligible studies through June 11, 2019. All analyses were performed with Stata 14.0. Subgroup analyses were performed by cancer type, ethnicity, source of control, and detection method. A total of 37 studies with 23,537 cases and 30,649 controls were included in this meta-analysis. Results XRCC3 rs1799794 increased cancer risk in the dominant model and heterozygous model (GG + AG vs. AA: odds ratio [OR] = 1.04, 95% confidence interval [CI] = 1.00-1.08, P = 0.051; AG vs. AA: OR = 1.05, 95% CI = 1.00-1.01, P = 0.015). The existence of rs1799794 increased the risk of breast cancer and thyroid cancer, but reduced the risk of ovarian cancer. In addition, rs1799794 increased the risk of cancer in the Caucasian population. Conclusion This meta-analysis confirms that XRCC3 rs1799794 is related to cancer risk, especially increased risk for breast cancer and thyroid cancer and reduced risk for ovarian cancer. However, well-designed large-scale studies are required to further evaluate the results.

作者

我是这篇论文的作者
点击您的名字以认领此论文并将其添加到您的个人资料中。

评论

主要评分

4.5
评分不足

次要评分

新颖性
-
重要性
-
科学严谨性
-
评价这篇论文

推荐

暂无数据
暂无数据